에 대한 최신 뉴스 Outfront Media (NYSE:OUT) 주식

Outfront Media

Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.

Outfront Media Inc

OUTBACK OIL&MNRL EXPL CRP by Outback Oil & Mineral Exploration Corp.

Outback Oil & Mineral Exploration Corp

Outokumpu Oyj

OUTSOURCING Inc

RAND MERCHANT INVT HLDG by Rand Merchant Invt Hldgs Ltd.

OUTsurance Group Ltd

Outbrain Inc

OUTCROP SILVER & GOLD CP by Outcrop SILVER & GOLD CORP.

Outcrop Silver & Gold Corp

OUTDOOR SPECIALTY PRODS by Outdoor Specialty Prods Inc

Outdoor Specialty Products Inc

Outfront Cos

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics Inc

Outset Medical Inc

BMO Capital analyst Ari Klein maintains SBA Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) with a Market Perform and raises the price target from $230 to $240.

News

Price Target

Analyst Ratings

SBAC

BMO Capital Maintains Market Perform on SBA Communications, Raises Price Target to $240

UBS analyst Pradeep Ramani maintains Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) with a Buy and lowers the price target from $70 to $55.

MCHP

UBS Maintains Buy on Microchip Technology, Lowers Price Target to $55

AZZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) has outperformed the market over the past 20 years by 8.88% on an annualized basis producing an average annual return of 16.92%. Currently, AZZ has a market capitalization of $2.57 billion. 
Buying $1000 In AZZ: If an investor had bought $1000 of AZZ stock 20 years ago, it would be worth $22,594.59 today based on a price of $86.00 for AZZ at the time of writing.
<h3>AZZ's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745937911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

BMO Capital analyst Andrew Strelzik maintains Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Outperform and raises the price target from $515 to $540.

BMO Capital Maintains Outperform on Domino's Pizza, Raises Price Target to $540

UBS analyst Danielle Antalffy maintains InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Neutral and lowers the price target from $19 to $16.25.

INMD

UBS Maintains Neutral on InMode, Lowers Price Target to $16.25

BMO Capital analyst James Thalacker maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Outperform and raises the price target from $77 to $79.

BMO Capital Maintains Outperform on CMS Energy, Raises Price Target to $79

UBS analyst Timothy Arcuri maintains GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) with a Neutral and lowers the price target from $45 to $37.

UBS Maintains Neutral on GLOBALFOUNDRIES, Lowers Price Target to $37

Piper Sandler analyst James Fish maintains F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) with a Neutral and raises the price target from $262 to $269.

FFIV

Piper Sandler Maintains Neutral on F5, Raises Price Target to $269

UBS analyst Timothy Arcuri maintains Entegris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>) with a Neutral and lowers the price target from $115 to $90.

ENTG

UBS Maintains Neutral on Entegris, Lowers Price Target to $90

Piper Sandler analyst Matt O'Brien reiterates TransMedics Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) with a Overweight and raises the price target from $90 to $105.

Reiteration

TMDX

Piper Sandler Reiterates Overweight on TransMedics Group, Raises Price Target to $105

UBS analyst Timothy Arcuri maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Buy and lowers the price target from $215 to $165.

UBS Maintains Buy on ARM Holdings, Lowers Price Target to $165

Piper Sandler analyst Matthew Clark maintains Preferred Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFBC#NASDAQ">PFBC</a>) with a Overweight and lowers the price target from $108 to $96.

PFBC

Piper Sandler Maintains Overweight on Preferred Bank, Lowers Price Target to $96

Buybacks

Wells Fargo Board Authorizes $40B Stock Repurchase Program

<a href="https://x.com/JStein_WaPo/status/1917220665821634689" title="https://x.com/JStein_WaPo/status/1917220665821634689">https://x.com/JStein_WaPo/status/1917220665821634689</a>

AMZN

Washington Post Reporter, Jeff Stein, On X Posts "Amazon Spox now saying this was never under consideration for the main Amazon website. Says Amazon Haul has considered listing import price duties on certain products"

UBS analyst Timothy Arcuri maintains Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) with a Buy and lowers the price target from $30 to $22.

ALGM

UBS Maintains Buy on Allegro Microsystems, Lowers Price Target to $22

Stephens &amp; Co. analyst Michael Schmidt downgrades SpringWorks Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) from Buy to Neutral and lowers the price target from $77 to $47.

Downgrades

SWTX

Stephens & Co. Downgrades SpringWorks Therapeutics to Neutral, Lowers Price Target to $47

UBS analyst Matheus Enfeldt maintains Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) with a Neutral and lowers the price target from $10.5 to $9.9.

AGRO

UBS Maintains Neutral on Adecoagro, Lowers Price Target to $9.9

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Tuesday.
Shares of Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) rose sharply during Tuesday's session after the company reported better-than-expected first-quarter financial results and <a href="https://www.benzinga.com/quote/HON/earnings">raised its FY25 adjusted EPS guidance</a>.
Revenue grew 8% year-over-year (Y/Y, organic: +4% Y/Y) to $9.82 billion, beating the consensus of $9.59 billion. Adjusted EPS was $2.51 (+7% Y/Y), beating the consensus of $2.21.
Honeywell International shares climbed 4.9% to $210.54 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares jumped 23% to $34.99 after the company announced a collaboration with Novo Nordisk to offer a bundled package of all dose strengths of Wegovy on its platform.</li>
<li>Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) gained 21.1% to $8.81 after the company reported better-than-expected first-quarter EPS results and raised its FY25 EPS guidance.</li>
<li>Clarivate Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>) jumped 16.8% to $4.1950 after the company reported better-than-expected quarterly financial results.</li>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) jumped 16% to $24.90 as the company raised its FY2025 sales guidance.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) gained 15.7% to $22.22 following upbeat quarterly earnings.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) rose 14.8% to $9.19.</li>
<li>ProPetro Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUMP#NYSE">PUMP</a>) shares rose 11.2% to $5.86 after the company reported a first-quarter adjusted EPS and revenue beat.</li>
<li>TriMas Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRS#NYSE">TRS</a>) gained 11.2% to $23.34 following better-than-expected quarterly earnings.</li>
<li>Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) gained 10.4% to $87.96 after the company reported better-than-expected first-quarter adjusted EPS results.</li>
<li>Metsera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) rose 10.2% to $21.83.</li>
<li>EPWK Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) rose 9.4% to $15.00.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) gained 7% to $96.04 after the company reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance.</li>
<li>Noble Corporation plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) rose 6.4% to $22.36 after the company reported better-than-expected quarterly sales results.</li>
<li>Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) gained 5.3% to $156.47 following upbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Intraday Update

Markets

Movers

CECO

CLVT

EPWK

FOUR

Hims & Hers Health, Inc. Class A Common Stock

HIMS

KNSA

LZMH

MTSR

PUMP

Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday

Piper Sandler analyst Frank Schiraldi maintains Meridian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRBK#NASDAQ">MRBK</a>) with a Neutral and lowers the price target from $17 to $16.

MRBK

Piper Sandler Maintains Neutral on Meridian, Lowers Price Target to $16

UBS analyst Gavin Parsons maintains Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) with a Buy and raises the price target from $200 to $220.

Comments

Outfront Media

뉴스

에 대한 최신 뉴스 Outfront Media (NYSE:OUT) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌